组织卡德林17 (CDH17):使用数字图像分析对结肠直肠癌的重要预后决定因素
Lui Ng1, Wing Shan Yu2,3, Nilar Myat Aung2,3
1Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Cancer reports (Hoboken, N.J.)
|December 1, 2024
概括
通过自动化系统量化的卡德林17 (CDH17) 表达在结直肠癌 (CRC) 中升高,并与晚期疾病有关. 高CDH17水平预测CRC患者的整体存活率和无复发存活率较差.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 数字病理学数字病理学
背景情况:
- 结肠直肠癌 (CRC) 是一个重大的全球健康挑战,死亡率高.
- 有效的预后生物标志物对于改善CRC患者管理和生活质量至关重要.
研究的目的:
- 评估卡德林17 (CDH17) 组织表达在结直肠癌 (CRC) 的预后意义.
- 使用标准化的自动化免疫组织化学 (IHC) 平台,为CDH17评估提供数字化评分.
主要方法:
- 在150个追溯的CRC瘤组织中评估CDH17表达,使用自动化IHC.
- 通过计算机辅助的膜 (M) 评分和数字图像分析量化CDH17表达.
- 与临床病理因素相关的CDH17M评分,总生存率 (OS) 和使用卡普兰-梅尔和考克斯回归分析的无复发生存率 (RFS).
主要成果:
- 瘤组织中的CDH17表达显著高于正常的邻近组织 (p=0.0011).
- 升高的CDH17M评分与晚期TNM分期 (p<0.0162) 和远程转移 (p=0.0026) 相相关.
- 高的CDH17M得分与较差的生存状况 (p=0.0118) 和RFS (p=0.0021) 有显著的关联.
- CDH17 M 评分独立预测了不良的生理状况 (HR=2.296, p=0.0240) 和RFS (HR=2.489, p=0.0447).
结论:
- 通过自动化IHC和数字评分测量的CDH17表达量的增加与晚期结直肠癌分期有关.
- CDH17作为一个有价值的独立预后标记,用于预测CRC患者的生存结果.
相关概念视频
Cadherins in Tissue Organization
2.9K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
2.9K
Structure of Cadherins
3.3K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
3.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


